Search by job, company or skills
Chugai Pharmabody Research Pte. Ltd. (CPR) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Biopolis in Singapore, it aims to generate new antibody drugs based on Chugai's proprietary antibody engineering technologies, such as recycling antibody, sweeping antibody, bispecific antibody, various Fc engineered antibodies, cyclic peptides and other new antibody engineering technologies that are under development.
Position - Senior Scientist in Mid-size Molecule Unit
CPR is seeking a Senior Scientist with expertise in drug discovery utilizing novel organic chemistry and biotechnology platform. You will leverage your passion and creativity to lead mid-size molecule projects through the identification of drug candidates, collaborating with other multi-disciplinary teams to achieve a milestone of a project. The candidate will play a key role in driving our innovative drug discovery projects and cutting-edge technology development through the fusion of chemistry and biotechnology.
Key Responsibilities
Job Requirements
The applicant should be highly skilled in at least one of the following areas:
Qualifications
Interested applicants are invited to email their detailed resume, as well as their qualifications, availability, current and expected salary to:[Confidential Information]
For more information regarding our Company, you may refer to our website at:
We regret that only short-listed candidates will be notified
Date Posted: 04/09/2025
Job ID: 125482161